Table 1.
Baseline characteristics of 140 HIV-infected patients
| Characteristics | Total (n = 140) | TB Group (n = 70) | Control Group (n = 70) | P value |
| Gender: Male | 95 (68%) | 56 (80%) | 39 (56%) | 0.002 |
| Age, years, mean ± SD | 35.7 ± 7.6 | 34.4 ± 6.2 | 37.2 ± 8.7 | 0.028 |
| Body weight, Kgs, mean ± SD | 54.6 ± 9.6 | 54.7 ± 8.7 | 54.4 ± 10.6 | 0.827 |
| Body mass index, mean ± SD | 20.1 ± 2.9 | 19.7 ± 2.4 | 20.5 ± 3.4 | 0.097 |
| CD4 cell counts, cells/mm3, mean ± SD | 62 ± 74 | 61 ± 74 | 76 ± 75 | 0.823 |
| %CD4, median (IQR) | 5 ± 5 | 6 ± 5 | 5 ± 5 | 0.226 |
| Plasma HIV RNA, copies/ml, median (IQR) | 433,500 (169,000–750,000) | 505,000 (269,000–750,000) | 291,000 (94,600–714,000) | 0.014 |
| Plasma HIV RNA, Log copies/ml, median (IQR) | 5.6 (5.2–5.9) | 5.7 (5.4–5.9) | 5.6 (5.0–5.9) | 0.004 |
| ALP, mg/dl, median (IQR) | 98 (71–142) | 110 (75–154) | 91 (70–128) | 0.072 |
| AST, U/l, median (IQR) | 30 (20–50) | 36 (27–60) | 35 (26–47) | 0.371 |
| ALT, U/l, median (IQR) | 27 (19–42) | 27 (18–51) | 32 (22–49) | 0.169 |
| Total bilirubin, mg/dl, median (IQR) | 0.6 (0.4–0.7) | 0.6 (0.5–0.8) | 0.5 (0.4–0.7) | 0.051 |
IQR = interquartile range